https://biotechmorning.com/news/atacicept-iga-nephropathy-fda-decision Biotech Morning en 2026-07-03T14:25:50.614Z The Drug That Failed in Lupus Just Might Save Your Kidneys https://biotechmorning.com/news/fda-peptide-panel-conflicts-of-interest Biotech Morning en 2026-07-03T14:24:54.282Z The FDA Panel That Might Regulate Itself Into a Payday https://biotechmorning.com/news/roche-divarasib-beats-lumakras-krazati-kras-g12c Biotech Morning en 2026-07-03T14:23:59.371Z Roche Just Beat the KRAS Kings at Their Own Game https://biotechmorning.com/news/deaf-toddlers-hearing-gene-therapy-sensorion Biotech Morning en 2026-07-03T14:23:02.404Z These Deaf Toddlers Are Starting to Hear for the First Time https://biotechmorning.com/news/macrogenics-sells-factory-bora-pharmaceuticals Biotech Morning en 2026-07-03T14:22:14.205Z MacroGenics Just Sold Its Factory. That's Weirder Than It Sounds. https://biotechmorning.com/news/united-therapeutics-thymmune-thymus-acquisition Biotech Morning en 2026-07-03T14:21:19.963Z United Therapeutics Just Bought a Thymus. Yes, Really. https://biotechmorning.com/news/biotech-billion-dollar-shopping-spree-has-a-catch Biotech Morning en 2026-07-03T14:20:28.599Z Biotech's Billion-Dollar Shopping Spree Has a Catch https://biotechmorning.com/news/ipsen-two-acquisitions-one-week-memo-kartos Biotech Morning en 2026-07-03T14:19:32.564Z Ipsen Just Spent $2.5 Billion in One Week. What Are They Building? https://biotechmorning.com/news/bridgebio-billion-dollar-preferred-equity-sixth-street-kkr Biotech Morning en 2026-07-03T14:18:38.077Z Wall Street's Biggest Names Just Bet $1 Billion on One Biotech https://biotechmorning.com/news/merck-alzheimers-trial-mk-1167-halted Biotech Morning en 2026-07-02T14:26:53.847Z Merck Just Struck Out in Alzheimer's. Again. https://biotechmorning.com/news/takeda-insilico-600m-ai-drug-discovery-deal Biotech Morning en 2026-07-02T14:26:00.349Z Takeda Just Paid $600M to Let an AI Design Its Next Drugs https://biotechmorning.com/news/orca-bio-tregzi-fda-approval-blood-cancer Biotech Morning en 2026-07-02T14:25:06.180Z The Cell Therapy That Just Reinvented Bone Marrow Transplants https://biotechmorning.com/news/oral-carbapenem-utebzi-fda-approval Biotech Morning en 2026-07-02T14:24:13.462Z The Antibiotic That Just Escaped the Hospital https://biotechmorning.com/news/medicare-glp1-weight-loss-pilot-50-copay Biotech Morning en 2026-07-02T14:23:18.754Z Medicare Just Bet Billions That Weight-Loss Drugs Will Pay for Themselves https://biotechmorning.com/news/celea-180m-ipf-deupirfenidone-financing Biotech Morning en 2026-07-02T14:22:30.059Z $180M Says Investors Believe This Lung Drug Can Dethrone a Generic https://biotechmorning.com/news/fda-real-time-clinical-trial-data-streaming Biotech Morning en 2026-07-02T14:19:01.391Z The FDA Wants to Watch Your Clinical Trial Live. Like, Right Now. https://biotechmorning.com/news/startup-2-2-billion-alzheimers-deal Biotech Morning en 2026-07-02T14:17:33.491Z A Startup Just Bet $2.2 Billion That It Can Crack Alzheimer's https://biotechmorning.com/news/astrazeneca-cspc-kidney-disease-deal Biotech Morning en 2026-07-02T14:16:39.775Z AstraZeneca Just Bet $1.77B That Your Kidneys Are the Next Big Thing https://biotechmorning.com/news/vertex-casgevy-gene-therapy-toddlers-sickle-cell Biotech Morning en 2026-07-02T14:15:44.271Z The Two-Year-Old Who Might Never Know She Has Sickle Cell